New Formulation of Rotarix Removes the Need for Reconstitution
The new liquid formulation of Rotarix does not require reconstitution or dilution before use.
Diagnosis & Disease Information
Maternal RSV Vaccine Candidate Provides Protection for Infants in Phase 3 Trial
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
Single-Vial Presentation of Meningococcal Vaccine Menveo Gets FDA Approval
The Menveo 1-vial presentation does not require reconstitution before use and is expected to be broadly available in mid-2023.
Boostrix Approved for Use During Pregnancy to Prevent Pertussis in Infants
Effectiveness in preventing pertussis among infants younger than 2 months of age when administered during the third trimester of pregnancy was based on a reanalysis of data from an observational case-control study.
Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
ACIP: Updated Vaccine Guidance for the 2022-2023 Influenza Season
In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.
Study Shows Bivalent RSV Vaccine Candidate Provides Protection for Older Adults
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
FDA Authorizes Use of Novavax COVID-19 Vaccine, Adjuvanted in Adolescents
The FDA has expanded the EUA for the Novavax COVID-19 Vaccine, Adjuvanted to include adolescents 12 to 17 years of age to prevent COVID-19.
Novavax Submits EUA Request for COVID-19 Vaccine Booster
The submission is supported by data from the phase 3 PREVENT-19 trial and the phase 2 COV-BOOST trial.
FDA Authorizes Intradermal Use of Jynneos to Increase Supply During Monkeypox Outbreak
Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged <18 years.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...